Discovery of Galangin as a Potential DPP-4 Inhibitor That Improves Insulin-Stimulated Skeletal Muscle Glucose Uptake: A Combinational Therapy for Diabetes. [electronic resource]
- International journal of molecular sciences Mar 2019
Publication Type: Journal Article
1422-0067
10.3390/ijms20051228 doi
Animals Cell Proliferation--drug effects Diabetes Mellitus, Type 2 Dipeptidyl-Peptidase IV Inhibitors--chemistry Flavonoids--chemistry Glucose--metabolism Insulin--metabolism Models, Molecular Molecular Conformation Muscle, Skeletal--metabolism Protein Binding Rats Reproducibility of Results Structure-Activity Relationship